Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines

Neurobiology of Aging

Volumn 33, Issue 1, 2012, Pages 108-120

  Pop, Viorela ^a,b   Head, Elizabeth ^a,b,c   Berchtold, Nicole C ^b   Glabe, Charles G ^b   Studzinski, Christa M ^c   Weidner, Adam M ^c   Murphy, M Paul ^c   Cotman, Carl W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Abeta star 56 kDa; ADAM10; APP; Beta amyloid; C terminal fragments of APP; Canine; Cingulate; Dog; Insulin degrading enzyme; Neprilysin; Oligomer; Secretase; Temporal

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID BETA40 PROTEIN; AMYLOID BETA42 PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; OLIGOMER; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGED; AGING; AMYLOID PLAQUE; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DOG; ENTORHINAL CORTEX; EXTRACELLULAR SPACE; LIFESPAN; MOLECULAR WEIGHT; NEUROPATHOLOGY; NONHUMAN; OCCIPITAL CORTEX; PARIETAL CORTEX; PEPTIDE ANALYSIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; TEMPORAL CORTEX;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; DISEASE MODELS, ANIMAL; DOGS; HUMANS; PLAQUE, AMYLOID; TEMPORAL LOBE;

EID: 81355133985     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.02.008     Document Type: Article

References (48)

1. Barger S.W., DeWall K.M., Liu L., Mrak R.E., Griffin W.S. Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies. J. Neuropathol. Exp. Neurol 2008, 67:773-783.
2. Calderon-Garciduenas L., Maronpot R.R., Torres-Jardon R., Henriquez-Roldan C., Schoonhoven R., Acuna-Ayala H., Villarreal-Calderon A., Nakamura J., Fernando R., Reed W., Azzarelli B., Swenberg J.A. DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol. Pathol 2003, 31:524-538.
3. Cotman C.W., Head E. The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches. J. Alzheimers Dis 2008, 15:685-707.
4. Cummings B.J., Head E., Afagh A.J., Milgram N.W., Cotman C.W. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol. Learn. Mem 1996, 66:11-23.
5. Cummings B.J., Satou T., Head E., Milgram N.W., Cole G.M., Savage M.J., Podlisny M.B., Selkoe D.J., Siman R., Greenberg B.D., Cotman C.W. Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs. Neurobiol. Aging 1996, 17:653-659.
6. DeCarli C., Frisoni G.B., Clark C.M., Harvey D., Grundman M., Petersen R.C., Thal L.J., Jin S., Jack C.R., Scheltens P. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch. Neurol 2007, 64:108-115.
7. Fleischman D.A., Wilson R.S., Gabrieli J.D., Schneider J.A., Bienias J.L., Bennett D.A. Implicit memory and Alzheimer's disease neuropathology. Brain 2005, 128:2006-2015.
8. Fukumoto H., Cheung B.S., Hyman B.T., Irizarry M.C. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol 2002, 59:1381-1389.
9. Fukumoto H., Rosene D.L., Moss M.B., Raju S., Hyman B.T., Irizarry M.C. Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am. J. Pathol 2004, 164:719-725.
10. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
11. Head E., Callahan H., Muggenburg B.A., Cotman C.W., Milgram N.W. Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol. Aging 1998, 19:415-425.
12. Head E., McCleary R., Hahn F.F., Milgram N.W., Cotman C.W. Region-specific age at onset of beta-amyloid in dogs. Neurobiol. Aging 2000, 21:89-96.
13. Head E., Pop V., Vasilevko V., Hill M., Saing T., Sarsoza F., Nistor M., Christie L.A., Milton S., Glabe C., Barrett E., Cribbs D. A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta. J. Neurosci 2008, 28:3555-3566.
14. Johnstone E.M., Chaney M.O., Norris F.H., Pascual R., Little S.P. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res. Mol. Brain Res 1991, 10:299-305.
15. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
16. Kim M., Suh J., Romano D., Truong M.H., Mullin K., Hooli B., Norton D., Tesco G., Elliott K., Wagner S.L., Moir R.D., Becker K.D., Tanzi R.E. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum. Mol. Genet 2009, 18:3987-3996.
17. Kuchibhotla K.V., Goldman S.T., Lattarulo C.R., Wu H.Y., Hyman B.T., Bacskai B.J. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 2008, 59:214-225.
18. Kukar T., Murphy M.P., Eriksen J.L., Sagi S.A., Weggen S., Smith T.E., Ladd T., Khan M.A., Kache R., Beard J., Dodson M., Merit S., Ozols V.V., Anastasiadis P.Z., Das P., Fauq A., Koo E.H., Golde T.E. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat. Med 2005, 11:545-550.
19. Lambert M.P., Velasco P.T., Chang L., Viola K.L., Fernandez S., Lacor P.N., Khuon D., Gong Y., Bigio E.H., Shaw P., De Felice F.G., Krafft G.A., Klein W.L. Monoclonal antibodies that target pathological assemblies of Abeta. J. Neurochem 2007, 100:23-35.
20. Lemere C.A., Blusztajn J.K., Yamaguchi H., Wisniewski T., Saido T.C., Selkoe D.J. Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down Syndrome: Implications for initial events in amyloid plaque formation. Neurobiol. Dis 1996, 3:16-32.
21. Lesne S., Kotilinek L., Ashe K.H. Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience 2008, 151:745-749.
22. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
23. Masliah E., Westland C.E., Rockenstein E.M., Abraham C.R., Mallory M., Veinberg I., Sheldon E., Mucke L. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience 1997, 78:135-146.
24. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 1993, 10:243-254.
25. McGowan E., Pickford F., Kim J., Onstead L., Eriksen J., Yu C., Skipper L., Murphy M.P., Beard J., Das P., Jansen K., Delucia M., Lin W.L., Dolios G., Wang R., Eckman C.B., Dickson D.W., Hutton M., Hardy J., Golde T. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 2005, 47:191-199.
26. Murphy M.P., Beckett T.L., Ding Q., Patel E., Markesbery W.R., St Clair D.K., LeVine H., Keller J.N. Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiol. Dis 2007, 27:301-311.
27. Murphy M.P., LeVine H. Alzheimer's disease and the amyloid-beta peptide. J. Alzheimers Dis 2010, 19:311-323.
28. Nistor M., Don M., Parekh M., Sarsoza F., Goodus M., Lopez G.E., Kawas C., Leverenz J., Doran E., Lott I.T., Hill M., Head E. Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol. Aging 2007, 28:1493-1506.
29. Oddo S., Caccamo A., Tran L., Lambert M.P., Glabe C.G., Klein W.L., LaFerla F.M. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J. Biol. Chem 2006, 281:1599-1604.
30. Rofina J.E., Singh K., Skoumalova-Vesela A., van Ederen A.M., van Asten A.J., Wilhelm J., Gruys E. Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine. Amyloid 2004, 11:90-100.
31. Roher A.E., Lowenson J.D., Clarke S., Woods A.S., Cotter R.J., Gowing E., Ball M.J. beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:10836-10840.
32. Roher A.E., Esh C.L., Kokjohn T.A., Castaño E.M., Van Vickle G.D., Kalback W.M., Patton R.L., Luehrs D.C., Daugs I.D., Kuo Y.M., Emmerling M.R., Soares H., Quinn J.F., Kaye J., Connor D.J., Silverberg N.B., Adler C.H., Seward J.D., Beach T.G., Sabbagh M.N. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement 2009, 5:18-29.
33. Russell M.J., Bobik M., White R.G., Hou Y., Benjamin S.A., Geddes J.W. Age-specific onset of beta-amyloid in beagle brains. Neurobiol. Aging 1996, 17:269-273.
34. Russo C., Salis S., Dolcini V., Venezia V., Song X.H., Teller J.K., Schettini G. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Neurobiol. Dis 2001, 8:173-180.
35. Selkoe D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res 2008, 192:106-113.
36. Shimada A., Kuwamura M., Umemura T., Takada K., Ohama E., Itakura C. Modified Bielschowsky and immunohistochemical studies on senile plaques in aged dogs. Neurosci. Lett 1991, 129:25-28.
37. Smith-Swintosky V.L., Pettigrew L.C., Craddock S.D., Culwell A.R., Rydel R.E., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J. Neurochem 1994, 63:781-784.
38. Smith C.D., Chebrolu H., Wekstein D.R., Schmitt F.A., Jicha G.A., Cooper G., Markesbery W.R. Brain structural alterations before mild cognitive impairment. Neurology 2007, 68:1268-1273.
39. Spires T.L., Meyer-Luehmann M., Stern E.A., McLean P.J., Skoch J., Nguyen P.T., Bacskai B.J., Hyman B.T. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci 2005, 25:7278-7287.
40. Steinerman J.R., Irizarry M., Scarmeas N., Raju S., Brandt J., Albert M., Blacker D., Hyman B., Stern Y. Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch. Neurol 2008, 65:906-912.
41. Stoub T.R., Rogalski E.J., Leurgans S., Bennett D.A., Detoledo-Morrell L. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: Relation to memory function. Neurobiol. Aging 2008, 10.1016/j.neurobiolaging.2008.08.003.
42. Swanson K.S., Vester B.M., Apanavicius C.J., Kirby N.A., Schook L.B. Implications of age and diet on canine cerebral cortex transcription. Neurobiol. Aging 2009, 30:1314-1326.
43. Tekirian T.L., Cole G.M., Russell M.J., Yang F., Wekstein D.R., Patel E., Snowdon D.A., Markesbery W.R., Geddes J.W. Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains. Neurobiol. Aging 1996, 17:249-257.
44. Thinakaran G., Koo E.H. Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem 2008, 283:29615-29619.
45. Tyler S.J., Dawbarn D., Wilcock G.K., Allen S.J. alpha- and beta-secretase: profound changes in Alzheimer's disease. Biochem. Biophys. Res. Commun 2002, 299:373-376.
46. Wang D.S., Iwata N., Hama E., Saido T.C., Dickson D.W. Oxidized neprilysin in aging and Alzheimer's disease brains. Biochem. Biophys. Res. Commun 2003, 310:236-241.
47. Yang L.B., Lindholm K., Yan R., Citron M., Xia W., Yang X.L., Beach T., Sue L., Wong P., Price D., Li R., Shen Y. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med 2003, 9:3-4.
48. Younkin S.G. The role of A beta 42 in Alzheimer's disease. J. Physiol. Paris 1998, 92:289-292.